Hydralazine Hydrochloride Injection
Product Images NDC 43066-041

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 43066-041). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01-hydralazine-structural-formula (Image 01 Hydralazine Structural Formula)

Image-01-hydralazine-structural-formula (Image 01 Hydralazine Structural Formula)
Chemical structure of hydralazine hydrochloride, showing the molecular arrangement including a hydrazinyl group attached to a bicyclic ring system and associated hydrochloride (HCl) component.*
FDA Label Image

Image-02-container-label (Image 02 Container Label)

Image-02-container-label (Image 02 Container Label)
Label for Hydralazine Hydrochloride Injection, USP 20 mg/mL, a 1 mL single-dose vial for intramuscular or intravenous use. The product is manufactured for Baxter Healthcare Corporation, Deerfield, IL, and made in India. Storage instructions specify 20°C to 25°C (68°F to 77°F).*
FDA Label Image

Image-03-carton-label-01 (Image 03 Carton Label 01)

Image-03-carton-label-01 (Image 03 Carton Label 01)
The label for Hydralazine Hydrochloride Injection, USP shows a 20 mg/mL strength in a 25 x 1 mL single-dose vial pack. It is indicated for intramuscular or intravenous use and is labeled as Rx only. The label lists the active ingredient as hydralazine hydrochloride and includes inactives and preservatives. The product is manufactured by Baxter Healthcare Corporation.*
FDA Label Image

Image-04-carton-label-02 (Image 04 Carton Label 02)

Image-04-carton-label-02 (Image 04 Carton Label 02)
Box packaging label for Hydralazine Hydrochloride Injection, USP 20 mg/mL by Baxter Healthcare Corporation. The label specifies the product is for intramuscular or intravenous use and contains 25 single-dose 1 mL vials. It includes storage instructions at 20°C to 25°C and notes the product is sterile and nonpyrogenic.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.